Cargando…

Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro

OBJECTIVE: To evaluate the clinical efficacy and safety of baricitinib, a Janus kinase (JAK) inhibitor, in treating patient with progressing vitiligo, and to further explore the regulation of baricitinib on melanocytes (MCs) in vitro. METHODS: Four patients with progressing vitiligo were treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Jie, Huang, Xuan, Ma, Li-Ping, Qi, Fei, Wang, Si-Nian, Zhang, Zi-Qin, Wei, Shi-Nan, Gao, Ling, Liu, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160904/ https://www.ncbi.nlm.nih.gov/pubmed/35663493 http://dx.doi.org/10.1177/15593258221105370

Ejemplares similares

Application of Baricitinib in Dermatology
por: Zhang, Jingya, et al.
Publicado: (2022)

Excellent Repigmentation of Generalized Vitiligo with Oral Baricitinib Combined with NB-UVB Phototherapy
por: Li, Xinxin, et al.
Publicado: (2023)

Difficult-to-treat rheumatoid arthritis treated with Abatacept combined with Baricitinib: A case report
por: Qi, Jia-Ping, et al.
Publicado: (2023)

Proteomic Analysis of the Serum of Patients with Stable Vitiligo and Progressive Vitiligo
por: Li, Yi-Lei, et al.
Publicado: (2018)

Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
por: Qi, Fei, et al.
Publicado: (2021)

Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study
por: van der Heijde, Désirée, et al.
Publicado: (2018)

Fabrication of anti-vitiligo ointment containing Psoralea corylifolia: in vitro and in vivo characterization
por: Hussain, Irshad, et al.
Publicado: (2016)

In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
por: Petrone, Linda, et al.
Publicado: (2021)

Progressive vitiligo induced by recurrent melanoma
por: Nakai, Yasuo, et al.
Publicado: (2022)

Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo
por: Sun, Ming-Chen, et al.
Publicado: (2020)

Baricitinib for the treatment of rheumatoid arthritis
por: Urits, Ivan, et al.
Publicado: (2020)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Baricitinib for the Treatment of Alopecia Areata
por: Freitas, Egídio, et al.
Publicado: (2023)

Plant-Derived Compounds as Promising Therapeutics for Vitiligo
por: Pang, Yaobin, et al.
Publicado: (2021)

Short-term effectiveness of baricitinib in children with refractory and/or severe juvenile dermatomyositis
por: Wang, Zhaoling, et al.
Publicado: (2022)

Baricitinib is potentially effective in the treatment of refractory livedoid vasculopathy
por: Han, Yuyang, et al.
Publicado: (2022)

Identification of the Role of Wnt/β-Catenin Pathway Through Integrated Analyses and in vivo Experiments in Vitiligo
por: Zhao, Si-Jia, et al.
Publicado: (2021)

Vitiligo effectively treated with electrocautery needling technique
por: Yang, Lili, et al.
Publicado: (2020)

Research Progress on Targeted Antioxidant Therapy and Vitiligo
por: Zhang, Jingzhan, et al.
Publicado: (2022)

15. Eosinophilic pneumonitis secondary to baricitinib
por: Yein, Khin, et al.
Publicado: (2019)

Treatment of severe alopecia areata with baricitinib
por: Olamiju, Brianna, et al.
Publicado: (2019)

Baricitinib: Two Birds with One Stone
por: Saj, Fen, et al.
Publicado: (2022)

Chemical Vitiligo: A Subset of Vitiligo
por: Ghosh, Sanjay
Publicado: (2020)

Characterization and Changes of Lymphocyte Subsets in Baricitinib‐Treated Patients With Rheumatoid Arthritis: An Integrated Analysis
por: Tanaka, Yoshiya, et al.
Publicado: (2018)

Efficacy and safety of baricitinib in patients with refractory alopecia areata
por: Wang, Yuqian, et al.
Publicado: (2022)

Vitiligo /
por: Valderrabano Guitian, Agustín
Publicado: (1987)

Treating Vitiligo at the Angle of Lips: A Narrative Review
por: Kar, Bikash Ranjan, et al.
Publicado: (2022)

In vitro effect of immune regulatory cytokines on vitiligo pathogenesis
por: Singh, Mala, et al.
Publicado: (2014)

In vivo third-harmonic generation microscopy study on vitiligo patients
por: Liao, Yi-Hua, et al.
Publicado: (2019)

Atezolizumab Plus Bevacizumab-induced Recalcitrant Pyoderma Gangrenosum Treated with Baricitinib: A Case Report
por: KIM, Han Seul, et al.
Publicado: (2023)

Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review
por: Emery, Paul, et al.
Publicado: (2021)

Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life
por: Deprez, Valentine, et al.
Publicado: (2020)

Baricitinib for COVID-19: a suitable treatment?
por: Favalli, Ennio G, et al.
Publicado: (2020)

Baricitinib exposure during pregnancy in rheumatoid arthritis
por: Costanzo, Giulia, et al.
Publicado: (2020)

Baricitinib: Various toxicities: 7 case reports
Publicado: (2021)

Baricitinib/cisatracurium besilate: Rhabdomyolysis: case report
Publicado: (2021)

Baricitinib: Various toxicities: 7 case reports
Publicado: (2022)

Identification, Synthesis, and Characterization of Novel Baricitinib Impurities
por: Vaddamanu, Guruswamy, et al.
Publicado: (2023)

Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies
por: Taylor, Peter C., et al.
Publicado: (2023)

Vitíligo : revisión bibliográfica
por: Merales Aldana, Arturo
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_684nqqmu4pcmkh0sikknci7ado